Cargando…

Exosomal miRNAs in tumor microenvironment

Tumor microenvironment (TME) is the internal environment in which tumor cells survive, consisting of tumor cells, fibroblasts, endothelial cells, and immune cells, as well as non-cellular components, such as exosomes and cytokines. Exosomes are tiny extracellular vesicles (40-160nm) containing activ...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tan, Shiming, Xia, Longzheng, Yi, Pin, Han, Yaqian, Tang, Lu, Pan, Qing, Tian, Yutong, Rao, Shan, Oyang, Linda, Liang, Jiaxin, Lin, Jinguan, Su, Min, Shi, Yingrui, Cao, Deliang, Zhou, Yujuan, Liao, Qianjin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7164281/ https://www.ncbi.nlm.nih.gov/pubmed/32299469 http://dx.doi.org/10.1186/s13046-020-01570-6

Ejemplares similares

MiRNAs in Radiotherapy Resistance of Nasopharyngeal Carcinoma
por: Tian, Yutong, et al.
Publicado: (2020)

The functions and mechanisms of prefoldin complex and prefoldin-subunits
por: Liang, Jiaxin, et al.
Publicado: (2020)

The roles of long non-coding RNAs in lung cancer
por: Cao, Zhe, et al.
Publicado: (2022)

Exosomes in Nasopharyngeal Carcinoma
por: Zhou, Yujuan, et al.
Publicado: (2018)

Corrigendum: RAC1 Involves in the Radioresistance by Mediating Epithelial-Mesenchymal Transition in Lung Cancer
por: Tan, Shiming, et al.
Publicado: (2020)

RAC1 Involves in the Radioresistance by Mediating Epithelial-Mesenchymal Transition in Lung Cancer
por: Tan, Shiming, et al.
Publicado: (2020)

Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment
por: Tan, Shiming, et al.
Publicado: (2023)

Rac1, A Potential Target for Tumor Therapy
por: Liang, Jiaxin, et al.
Publicado: (2021)

Biological Function of HYOU1 in Tumors and Other Diseases
por: Rao, Shan, et al.
Publicado: (2021)

The cancer metabolic reprogramming and immune response
por: Xia, Longzheng, et al.
Publicado: (2021)

The roles of glucose metabolic reprogramming in chemo- and radio-resistance
por: Lin, Jinguan, et al.
Publicado: (2019)

The function of prohibitins in mitochondria and the clinical potentials
por: Oyang, Linda, et al.
Publicado: (2022)

The POU2F1-ALDOA axis promotes the proliferation and chemoresistance of colon cancer cells by enhancing glycolysis and the pentose phosphate pathway activity
por: Lin, Jinguan, et al.
Publicado: (2022)

Cancer stem cells in progression of colorectal cancer
por: Zhou, Yujuan, et al.
Publicado: (2017)

High expression of calreticulin indicates poor prognosis and modulates cell migration and invasion via activating Stat3 in nasopharyngeal carcinoma
por: Han, Yaqian, et al.
Publicado: (2019)

Role of the NFκB-signaling pathway in cancer
por: Xia, Longzheng, et al.
Publicado: (2018)

Organoids: opportunities and challenges of cancer therapy
por: Jiang, Xianjie, et al.
Publicado: (2023)

Exosomal miR-205-5p enhances angiogenesis and nasopharyngeal carcinoma metastasis by targeting desmocollin-2
por: Yang, Wenjuan, et al.
Publicado: (2022)

Clinical significance and integrative analysis of the cuproptosis-associated genes in head and neck squamous cell carcinoma
por: Peng, Qiu, et al.
Publicado: (2023)

Rac1 promotes the reprogramming of glucose metabolism and the growth of colon cancer cells through upregulating SOX9
por: Liang, Jiaxin, et al.
Publicado: (2022)

Metabolic reprogramming and epigenetic modifications in cancer: from the impacts and mechanisms to the treatment potential
por: Xu, Xuemeng, et al.
Publicado: (2023)

LPLUNC1 stabilises PHB1 by counteracting TRIM21-mediated ubiquitination to inhibit NF-κB activity in nasopharyngeal carcinoma
por: Wang, Heran, et al.
Publicado: (2019)

The role of tripartite motif-containing 28 in cancer progression and its therapeutic potentials
por: Yang, Yiqing, et al.
Publicado: (2023)

LPLUNC1 reduces glycolysis in nasopharyngeal carcinoma cells through the PHB1‐p53/c‐Myc axis
por: Oyang, Linda, et al.
Publicado: (2022)

Diallyl disulfide inhibits colon cancer metastasis by suppressing Rac1-mediated epithelial-mesenchymal transition
por: Xia, Longzheng, et al.
Publicado: (2019)

Exosomal miRNAs in the Tumor Microenvironment of Multiple Myeloma
por: Alipoor, Shamila D., et al.
Publicado: (2023)

Phase separation in Cancer: From the Impacts and Mechanisms to Treatment potentials
por: Peng, Qiu, et al.
Publicado: (2022)

Role of Exosomal miRNAs and the Tumor Microenvironment in Drug Resistance
por: Santos, Patrick, et al.
Publicado: (2020)

Overexpression of PAK1 Correlates with Aberrant Expression of EMT Markers and Poor Prognosis in Non-Small Cell Lung Cancer
por: Yang, Zhiying, et al.
Publicado: (2017)

Rac1 overexpression is correlated with epithelial mesenchymal transition and predicts poor prognosis in non-small cell lung cancer
por: Zhou, Yujuan, et al.
Publicado: (2016)

The Tumor Cytosol miRNAs, Fluid miRNAs, and Exosome miRNAs in Lung Cancer
por: Qin, Xin, et al.
Publicado: (2015)

Exosomal MiRNAs in Pediatric Cancers
por: Galardi, Angela, et al.
Publicado: (2019)

The role of Exosomal miRNAs in cancer
por: Li, Chuanyun, et al.
Publicado: (2022)

Differential expression analysis of miRNAs in macrophage-derived exosomes in the tuberculosis-infected bone microenvironment
por: Sun, Zhicheng, et al.
Publicado: (2023)

Emerging Exosomes and Exosomal MiRNAs in Spinal Cord Injury
por: Feng, Jia, et al.
Publicado: (2021)

Roles of exosomes and exosome-derived miRNAs in pulmonary fibrosis
por: Yang, Yongfeng, et al.
Publicado: (2022)

Exosomal miRNAs and miRNA dysregulation in cancer-associated fibroblasts
por: Yang, Fengming, et al.
Publicado: (2017)

Exosomal miRNAs as Biomarkers for Prostate Cancer
por: Hessvik, Nina Pettersen, et al.
Publicado: (2013)

Inflammasomes: Exosomal miRNAs loaded for action
por: Matikainen, Sampsa, et al.
Publicado: (2020)

Role of Exosomal miRNAs in Heart Failure
por: Xue, Ruicong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_tg2kb53vsn5ot8gvesma5b7i9s